<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Cosmi B</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>The post-thrombotic syndrome (PTS) is the most common long-term complication of deep vein thrombosis (DVT), occurring in up to 40-50% of cases. There are limited evidence-based approaches for PTS clinical management.&lt;h4>Objective&lt;/h4>To provide an expert consensus for PTS diagnosis, prevention, and treatment.&lt;h4>Evidence-review&lt;/h4>MEDLINE, Cochrane Database review, and GOOGLE SCHOLAR were searched with the terms "post-thrombotic syndrome" and "post-phlebitic syndrome" used in titles and abstracts up to September 2020.&lt;h4>Filters were&lt;/h4>English, Controlled Clinical Trial / Systematic Review / Meta-Analysis / Guideline. The relevant literature regarding PTS diagnosis, prevention and treatment was reviewed and summarized by the evidence synthesis team. On the basis of th</pubmed_abstract><journal>Frontiers in cardiovascular medicine</journal><pagination>762443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8907532</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.</pubmed_title><pmcid>PMC8907532</pmcid><pubmed_authors>Gresele P</pubmed_authors><pubmed_authors>Prior M</pubmed_authors><pubmed_authors>Righini M</pubmed_authors><pubmed_authors>Lessiani G</pubmed_authors><pubmed_authors>Wennberg PW</pubmed_authors><pubmed_authors>Stanek A</pubmed_authors><pubmed_authors>Kozak M</pubmed_authors><pubmed_authors>Lichtenberg M</pubmed_authors><pubmed_authors>Catalano M</pubmed_authors><pubmed_authors>Klein-Wegel P</pubmed_authors><pubmed_authors>De Marchi S</pubmed_authors><pubmed_authors>Cosmi B</pubmed_authors><pubmed_authors>Pecsvarady Z</pubmed_authors><pubmed_authors>Puskas A</pubmed_authors><pubmed_authors>Farkas K</pubmed_authors><pubmed_authors>Marschang P</pubmed_authors><pubmed_authors>Kolluri R</pubmed_authors><pubmed_authors>Poredos P</pubmed_authors><pubmed_authors>Szuba A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.</name><description>&lt;h4>Importance&lt;/h4>The post-thrombotic syndrome (PTS) is the most common long-term complication of deep vein thrombosis (DVT), occurring in up to 40-50% of cases. There are limited evidence-based approaches for PTS clinical management.&lt;h4>Objective&lt;/h4>To provide an expert consensus for PTS diagnosis, prevention, and treatment.&lt;h4>Evidence-review&lt;/h4>MEDLINE, Cochrane Database review, and GOOGLE SCHOLAR were searched with the terms "post-thrombotic syndrome" and "post-phlebitic syndrome" used in titles and abstracts up to September 2020.&lt;h4>Filters were&lt;/h4>English, Controlled Clinical Trial / Systematic Review / Meta-Analysis / Guideline. The relevant literature regarding PTS diagnosis, prevention and treatment was reviewed and summarized by the evidence synthesis team. On the basis of th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-18T20:23:02.854Z</modification><creation>2025-04-07T08:19:12.586Z</creation></dates><accession>S-EPMC8907532</accession><cross_references><pubmed>35282358</pubmed><doi>10.3389/fcvm.2022.762443</doi></cross_references></HashMap>